Tech Company Financing Transactions

Sardine Funding Round

On 2/18/2022, Sardine raised $19.5 million in Series A investment from private investors and Experian.

Transaction Overview

Company Name
Announced On
2/18/2022
Transaction Type
Venture Equity
Amount
$19,500,000
Round
Series A
Investors

private investors (Lead Investor) (Andreessen Horowitz)

Experian

Proceeds Purpose
Our investment in Sardine is perfectly aligned to Experian's fraud capabilities and our work to stop fraud in digital commerce and payments," said Kathleen Peters, Chief Innovation Officer, Experian Decision Analytics in North America. "Sardine is on the path to being a market leader in preventing financial crime with their talented team and innovative products. Experian is always looking for new investments and partners that can bring groundbreaking technology and problem-solving solutions to the market

Company Information

Company Status
Private & Independent
Industry
Security
Mailing Address
164 Townsend St. 9
San Francisco, CA 94107
USA
Phone
Undisclosed
Email Address
Overview
Sardine is a Fraud Prevention-as-a-Service (FaaS) platform for Digital businesses to detect all types of fraud and financial crimes: Identity fraud at account opening; Payment fraud at account funding via cards or ACH; Account takeovers at login; Suspicious activities during deposits or withdrawals.
Profile
Sardine LinkedIn Company Profile
Social Media
Sardine Company Twitter Account
Company News
Sardine News
Facebook
Sardine on Facebook
YouTube
Sardine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Soups Ranjan
  Soups Ranjan LinkedIn Profile  Soups Ranjan Twitter Account  Soups Ranjan News  Soups Ranjan on Facebook
Co-Founder
Aditya Goel
  Aditya Goel LinkedIn Profile  Aditya Goel Twitter Account  Aditya Goel News  Aditya Goel on Facebook
VP - Product Management
Zahid Shaikh
  Zahid Shaikh LinkedIn Profile  Zahid Shaikh Twitter Account  Zahid Shaikh News  Zahid Shaikh on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/18/2022: Ventus Therapeutics venture capital transaction
Next: 2/18/2022: Arkuda Therapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary